ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,409,189, issued on Sept. 9, was assigned to University of Utah Research Foundation (Salt Lake City).

"STAUFEN1 agents and associated methods" was invented by Stefan M. Pulst (Sandy, Utah), Daniel R. Scoles (Salt Lake City) and Sharan Paul (Salt Lake City).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of minimizing dysregulation of Staufen1-associated RNA metabolism can include introducing an amount of a Staufen1-regulating agent to a target cell sufficient to minimize the dysregulation. Therapeutic compositions for treating a neurodegenerative condition associated with Staufen1-induced dysregulation of RNA metabolism can include a therapeutical...